Breast Cancer

Laura A. Huppert, MD

Assistant Professor, Department of Medicine, Division of Hematology and Oncology, UCSF School of Medicine; Breast Medical Oncologist, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Dr Huppert earned her medical degree at Harvard Medical School. She completed her internal medicine residency and hematology/oncology fellowship at UCSF before starting on faculty there. Dr Huppert is interested in clinical and translational breast cancer research in both early-stage and metastatic disease. She is involved in the I-SPY 2 clinical trial for neoadjuvant therapy in early-stage breast cancer and serves as chairperson of the Metastatic Disease Working Group and the Endocrine Optimization Protocol Safety Working Group. Dr Huppert is also interested in designing clinical trials with novel therapies for patients with metastatic breast cancer and leads several investigator-initiated clinical trials. She has received an ASCO Merit Award, a California Breast Cancer Research Program IDEA Award, and is currently the recipient of the Helen Diller Family Comprehensive Cancer Center K12 Physician Scientist Program in Clinical Oncology.

Hope S. Rugo, MD, FASCO

Winterhof Family Endowed Professorship in Breast Cancer; Professor, Department of Medicine, Division of Hematology and Oncology, UCSF School of Medicine; Director, Breast Oncology and Clinical Trials Education; Medical Director, Cancer Infusion Services, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Dr Rugo is a professor of medicine in the Division of Hematology and Oncology at the UCSF School of Medicine. She is director of Breast Oncology and Clinical Trials Education at UCSF Helen Diller Family Comprehensive Cancer Center. Dr Rugo is an internationally recognized expert in breast cancer. Her research interests include novel therapies for advanced breast cancer, immune modulation to restore chemotherapy sensitivity, evaluation of circulating tumor DNA as a marker of response and resistance to therapy, neoadjuvant therapy, and safety/supportive care.

Dr Rugo is a principal investigator of multiple clinical trials and has published widely in medical journals. Dr Rugo also plays an active role in the Alliance for Clinical Trials in Oncology, the Translational Breast Cancer Research Consortium, American Society of Clinical Oncology, Multinational Association of Supportive Care in Cancer, and international guideline committees, including the National Comprehensive Cancer Network. Dr Rugo is dedicated to education and mentorship, providing guidance to medical students, residents, and fellows at UCSF and beyond.